ReviewFood science & nutrition2026
The Role of Gut Microbiome in Obesity and Weight Management: A Review of Current Evidence and Future Directions.
Review in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanisms of Obesity-Related Kidney Disease: From Adipose Depot Biology to the Chymase-Aldosterone and Ghrelin-Leptin Axes.Biomolecules · 2026Review
- Gut Microbiome-Hormone Interactions and Precision Fermentation in the Prevention of Early Cardiovascular Risk in Adolescents.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity has become an emerging challenge all over the world. In 2022, one in eight people was living with obesity. It is most common in adults and children. It is due to an imbalance between energy consumption and utilization. However, the human gut microbiome regulates energy metabolism, a complex ecosystem of microorganisms residing in the gastrointestinal tract, which stimulates hormone production, produces various metabolites, and interacts with brain responses involved in maintaining energy balance in the body. Dysbiosis, characterized by an imbalance in microbial composition, has been linked to increased energy harvesting, impaired bile acid metabolism, chronic low-grade inflammation, impaired appetite regulation, and excessive intake, ultimately leading to obesity. The primary focus of this review is to discuss the current understanding of the roles of diet, exercise, pharmacological agents, and surgery in shaping gut microbial communities and host physiology. Dietary interventions, such as the use of probiotics, prebiotics, high-fiber diets, ketogenic diets, and intermittent fasting, modulate microbial metabolites like short-chain fatty acids, which play a crucial role in regulating energy balance and inflammation, thereby contributing to the prevention of weight gain. Physical activity induces positive changes in gut microbiota, enhancing metabolic adaptability and supporting immune system regulation. Pharmacological treatments, especially anti-obesity and anti-diabetic drugs, have both direct and microbiota-mediated effects on weight and glucose metabolism. Similarly, surgery leads to significant changes in gut microbiota, which play a role in long-term enhancements in metabolic health. So, this review aims to discuss various weight management approaches targeting the gut microbiome, drawing on current studies. However, these interventions require further investigation for their effectiveness.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.